We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$17B
AUM Growth
-$1.5B
Cap. Flow
-$3.24B
Cap. Flow %
-19.02%
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 27.35%
2 Financials 13.45%
3 Industrials 10.46%
4 Healthcare 10.18%
5 Communication Services 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
576
Acuity Brands
AYI
$10.8B
$4.92M 0.03%
16,485
-543
-3% -$141K
NYT icon
577
New York Times
NYT
$10.3B
$4.89M 0.03%
87,349
-3,218
-4% -$171K
BPMC
578
DELISTED
Blueprint Medicines
BPMC
$4.89M 0.03%
38,125
+611
+2% +$63.5K
MKC icon
579
McCormick & Company Non-Voting
MKC
$14.2B
$4.88M 0.03%
64,389
-1,182
-2% -$88.6K
PRI icon
580
Primerica
PRI
$9.57B
$4.84M 0.03%
17,696
-833
-4% -$221K
EL icon
581
Estee Lauder
EL
$31.7B
$4.82M 0.03%
59,667
-4,709
-7% -$303K
OGE icon
582
OGE Energy
OGE
$9.69B
$4.81M 0.03%
108,404
-3,163
-3% -$140K
OGS icon
583
ONE Gas
OGS
$5.05B
$4.81M 0.03%
66,940
+3,670
+6% +$276K
VLY icon
584
Valley National Bancorp
VLY
$8.25B
$4.8M 0.03%
537,856
+10,247
+2% +$89K
IFF icon
585
International Flavors & Fragrances
IFF
$21.4B
$4.79M 0.03%
65,180
-1,226
-2% -$92.6K
LAD icon
586
Lithia Motors
LAD
$8.32B
$4.78M 0.03%
14,141
-643
-4% -$199K
DOCS icon
587
Doximity
DOCS
$4.45B
$4.77M 0.03%
77,782
+3,380
+5% +$189K
DOW icon
588
Dow Inc
DOW
$22.1B
$4.77M 0.03%
180,121
-2,683
-1% -$78K
AIT icon
589
Applied Industrial Technologies
AIT
$13B
$4.77M 0.03%
20,509
-22,432
-52% -$5.1M
REXR icon
590
Rexford Industrial Realty
REXR
$8.11B
$4.76M 0.03%
133,860
+1,138
+0.9% +$39.7K
ROL icon
591
Rollins
ROL
$17.6B
$4.76M 0.03%
84,390
-688
-0.8% -$38.6K
LUV icon
592
Southwest Airlines
LUV
$22B
$4.76M 0.03%
146,673
-7,340
-5% -$221K
EAT icon
593
Brinker International
EAT
$10.5B
$4.76M 0.03%
26,384
+770
+3% +$121K
SR icon
594
Spire
SR
$4.89B
$4.76M 0.03%
65,148
+820
+1% +$61.4K
WY icon
595
Weyerhaeuser
WY
$17.8B
$4.75M 0.03%
184,791
-3,722
-2% -$97.4K
LNW
596
DELISTED
Light & Wonder
LNW
$4.73M 0.03%
49,177
-3,720
-7% -$319K
MLI icon
597
Mueller Industries
MLI
$15.1B
$4.73M 0.03%
119,090
-132,820
-53% -$5.01M
MORN icon
598
Morningstar
MORN
$7.41B
$4.71M 0.03%
15,008
-1,151
-7% -$341K
ORI icon
599
Old Republic International
ORI
$10.3B
$4.71M 0.03%
122,463
-7,047
-5% -$265K
MTSI icon
600
MACOM Technology Solutions
MTSI
$23.7B
$4.7M 0.03%
32,823
-252
-0.8% -$29.4K

Similar funds

MetLife Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.

  • MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
  • MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
  • MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
  • MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
  • MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
  • MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.